Moreover, results from Kaplan‐Meier survival analyses revealed that SUZ12 up‐regulation was significantly associated with reduced survival, thus suggesting that SUZ12 might be promising prognostic biomarkers for HNSCC. This evidence concerns the gene SUZ12 and head and neck squamous cell carcinoma.